Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 220 clinical trials
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors (STELLAR-002)

administered alone, and in combination with nivolumab (doublet), nivolumab + ipilimumab (triplet), and nivolumab + bempegaldesleukin (triplet) in subjects with advanced solid tumors. In the Expansion

measurable disease
metastatic transitional cell carcinoma
vegf
nivolumab
ipilimumab
  • 0 views
  • 25 Apr, 2022
  • 1 location
Axitinib + Ipilimumab in Advanced Melanoma

The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.

hepatitis
unresectable melanoma
BRAF
measurable disease
immunologic adjuvant
  • 0 views
  • 24 Mar, 2022
  • 1 location
NeoVax Plus Ipilimumab in Renal Cell Carcinoma

will be involved in this study: Personalized Neoantigen Vaccine Poly-ICLC (Hiltonol) Ipilimumab

neutrophil count
cancer
clear cell renal cell carcinoma
carcinoma
ipilimumab
  • 0 views
  • 08 Apr, 2022
Ipilimumab for Head and Neck Cancer Patients

This study is for patients with squamous cell carcinoma of the head and neck (SCCHN). This study will test the feasibility of the administration of intratumoral injections of ipilimumab prior to

head and neck cancer
cancer
neck cancer
head and neck carcinoma
squamous cell carcinoma
  • 0 views
  • 24 Mar, 2022
  • 1 location
Surgical Nivolumab And Ipilimumab For Recurrent GBM

This research trial is studying the safety and effectiveness of nivolumab in combination with ipilimumab and surgery when used in the treatment of recurrent glioblastoma. The names of the

neutrophil count
gliosarcoma
tumor progression
stereotactic biopsy
aptt
  • 0 views
  • 22 Mar, 2022
  • 2 locations
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer

This research is being done to study the effects of the combination of ipilimumab, nivolumab, and radiation therapy in people with microsatellite stable pancreatic cancer. The names of

neutrophil count
thromboplastin
anticoagulants
measurable disease
nivolumab
  • 0 views
  • 25 Jan, 2021
Infliximab for Treatment of Ipilimumab Colitis

This research study is evaluating the effectiveness and safety of infliximab therapy compared with steroids in the treatment of ipilimumab-induced colitis in patients with III/IV melanoma.

endoscopy
hepatitis b surface antigen
infliximab
prednisone
prednisolone
  • 10 views
  • 06 Nov, 2021
Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer (CHINOREC)

This prospective randomized, open-label, multicenter, phase II clinical trial investigates the safety and tolerability of standard neoadjuvant chemoradiotherapy (CRT) with sequential ipilimumab

carcinoma
chemoradiotherapy
capecitabine
  • 0 views
  • 19 Apr, 2022
  • 5 locations
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

In this study, the Phase Ib portion aims to establish safety and tolerability of ARRY-614 with either nivolumab or ipilimumab and to determine a recommended phase II dose of ARRY-614 in

neutrophil count
immunodeficiency
measurable disease
nivolumab
serum pregnancy test
  • 14 views
  • 25 Mar, 2022
  • 1 location
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer (CYTOSHRINK)

This trial will evaluate the addition of cytoreductive stereotactic body radiation therapy (SBRT) to standard of care combination ipilimumab and nivolumab (I/N) versus I/N alone for the

metastasis
cancer
nivolumab
kidney cancer
ipilimumab
  • 0 views
  • 23 Apr, 2022
  • 6 locations